September 2026 E-Update
The New NETRF Patient Guide Is Here | The Latest on GLP-1s and Neuroendocrine Cancer Inbox
October 2, 2026
The Neuroendocrine Tumor Research Foundation (NETRF) is the leading private funder of research into causes and treatments of neuroendocrine tumors (NETs) to improve and extend the lives of those living with NETs.
The New NETRF Patient Guide Is Here | The Latest on GLP-1s and Neuroendocrine Cancer Inbox
Neuroendocrine Carcinoma vs. Neuroendocrine Tumors | Voices of Neuroendocrine Cancer Thrivership
New Insights Into the Patient Experience | How One 15-Year Old Is Making a Difference
One researcher’s personal neuroendocrine cancer story | Save the dates for patient programs
Last call for annual patient and caregiver survey | NETRF RFA opens
Neuroendocrine Cancer Awareness Month | Patient Perspectives on Radioligand Therapy
The latest promising trial results | The Healing Garden by Jake Dawson
New Insights on Nutrition, An Educator’s Quest to Inform Herself and Others
We welcome seven new members to our Board of Scientific Advisors and feature a blog from patient Jake Dawson, among other stories.
